People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
All three indexes are on track for their third straight week of gains. Among other stocks, Bristol-Myers Squibb surged 3.2% ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The ...